MYX Share Price Performance
AU$0
-5.29 (-100.00%)
Price AU$0
Fair ValueAU$5.75
Share Pricen/a
New Narrative • May 01
Mayne Pharma Group Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 11 Fair Values set on narratives written by author
MYX Community Narratives
AN
Fair Value
·Fair Value AU$5.75 58.1% undervalued intrinsic discount
Women’s Health Trends And Dermatology Platform Will Reshape Long-Term Earnings Profile
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Women’s Health Trends And Dermatology Platform Will Reshape Long-Term Earnings Profile
Catalysts About Mayne Pharma Group Mayne Pharma Group focuses on branded and specialty pharmaceutical products in Women's Health, Dermatology and International markets. What are the underlying business or industry changes driving this perspective?Read more
AN
AU$5.75
58.1% undervalued intrinsic discount
Fair Value
Profit Margin
10.01%
Future PE
13.7x
Price in 2029
AU$7.02
Trending Discussion
Recently Updated Narratives
AN
Women’s Health Trends And Dermatology Platform Will Reshape Long-Term Earnings Profile
Fair Value: AU$5.75 58.1% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Mayne Pharma Group Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -1.01
- 62.64%
- -20.19%
- 10.5%
About MYX
- Founded
- 2005
- Employees
- 491
- CEO
- WebsiteView website
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women’s Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
